Magnetic resonance characterization of tumor microvessels in experimental breast tumors using a slow clearance blood pool contrast agent (carboxymethyldextran-A2-Gd-DOTA) with histopathological correlation

European Radiology

Volumn 15, Issue 11, 2005, Pages 2268-2275

  Preda, Anda ^a,b   Novikov, Viktor ^a   Möglich, Martina ^a   Floyd, Eugenia ^c   Turetschek, Karl ^a   Shames, David M ^a   Roberts, Timothy P ^a   Corot, Claire ^d   Carter, Wayne O ^c   Brasch, Robert C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

^d Laboratoire Guerbet   (France)

Author keywords

Breast neoplasms; Carboxymethyldextran A2 Gd DOTA; Contrast media; Dynamic contrast enhancement; Magnetic resonance imaging

Indexed keywords

CARBOXYMETHYLDEXTRAN; GADOTERIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VOLUME; BODY WEIGHT; BREAST CANCER; BREAST TUMOR; CANCER GRADING; COMPARTMENT MODEL; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIFFERENTIAL DIAGNOSIS; DRUG CLEARANCE; HISTOPATHOLOGY; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE ENHANCEMENT; MICROVASCULATURE; MOLECULAR WEIGHT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RAT; RAT STRAIN; THREE DIMENSIONAL IMAGING;

ANIMALS; MAGNETIC RESONANCE IMAGING; MAMMARY NEOPLASMS, EXPERIMENTAL; MICROCIRCULATION; ORGANOMETALLIC COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 27744433258     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-005-2823-9     Document Type: Article

References (40)

1. Turetschek K, Preda A, Floyd E, Shames DM, Novikov V, Roberts TPL, Wood JM, Fu Y, Carter WO, Brasch RC (2003) MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model. Eur J Nucl Med 30:448-455
2. Pham CD, Roberts TPL, van Bruggen N, Melnyk O, Mann J, Ferrara N, Cohen RL, Brasch RC (1998) Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest 6:225-230
3. Daldrup H, Shames DM, Wendland M, Okuhata Y, Link TM, Rosenau W, Lu Y, Brasch RC (1998) Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: Comparison of macromolecular and small-molecular contrast media. Am J Roentgenol 171:941-949
4. Brasch RC, Shames DM, Cohen FM, Kuwatsuru R, Neuder M, Mann JS, Vexler V, Muhler A, Rosenau W (1994) Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas. Invest Radiol 29 [Suppl 2]:S8-S11
5. Su MY, Wang Z, Carpenter PM, Lao X, Muhler A, Nalcioglu O (1999) Characterization of N-ethyl-N-nitrosourea-induced malignant and benign breast tumor in rats by using three MR contrast agents. J Magn Reson Imaging 9:177-186 10077011
6. Schwickert HC, Stiskal M, Roberts TP, van Dijke CF, Mann J, Muhler A, Shames DM, Demsar F, Disston A, Brasch RC (1996) Contrast-enhanced MR imaging assessment of tumor capillary permeability: Effect of irradiation on delivery of chemotherapy. Radiology 198:893-898 8628889
7. Gossmann A, Okuhata Y, Shames DM, Helbich TH, Roberts TPL, Wendland MF, Huber S, Brasch RC (1999) Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: Comparison of macromolecular and small-molecular contrast media-preliminary experience. Radiology 213:265-272 10540670
8. Jain R (1994) Barriers to drug devivery in solid tumors. Sci Am 271:58-65
9. White D, Wang S-C, Aicher K, Dupon J, Engelstad B, Brasch R (1989) Albumin-(Gd-DTPA)15-20: Whole body clearance, and organ distribution of gadolinium. In: Proceedings of the Society of Magnetic Resonance in Medicine, 8th Annual Meeting, Amsterdam, p 807
10. Baxter AB, Melnikoff S, Stites DP, Brasch RC (1991) Immunogenicity of gadolinium-based contrast agents for MRI. Invest Radiol 26:1035-1040 1722486
11. Turetschek K, Floyd E, Shames DM, Roberts TPL, Preda A, Novikov V, Corot C, Carter WO, Brasch RC (2001) Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlation to histopathology. Magn Reson Med 45:880-886 11323815
12. Turetschek K, Floyd E, Helbich T, Roberts TPL, Shames DM, Wendland MF, Carter WO, Brasch RC (2001) MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlation to histopathology. J Magn Reson Imaging 14:237-242 11536400
13. Turetschek K, Huber S, Floyd E, Helbich T, Roberts TPL, Shames DM, Tarlo KS, Wendland MF, Brasch RC (2001) MR imaging characterization of microvessels in experimental breast tumors by using a particulate contrast agent with histopathologic correlation. Radiology 218:562-569 11161179
14. Turetschek K, Roberts TPL, Floyd E, Preda A, Novikov V, Shames DM, Carter WO, Brasch RC (2001) Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model. J Magn Reson Imaging 13:882-888 11382948
15. Corot C, Schaffer M, Beaute S, Bourrinet P, Zehaf S, Benize V, Sabatou M, Meyer D (1997) Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer. Acta Radiol 412 [Suppl]:91-99
16. Canet EP, Casali C, Desenfant A, An MY, Corot C, Obadia JF, Revel D, Janier MF (2000) Kinetic characterization of CMD-A2-Gd-DOTA as an intravascular contrast agent for myocardial perfusion measurements with MRI. Magn Reson Med 43:403-409 10725883
17. Mandybur T (1985) Neural, pituitary and mammary tumors in Sprague Dawley rats treated with x-irradiation to the head and N-ethyl-N-nitrosourea (ENU) during the early postnatal period: A statistical study of tumor incidence and survival. Radiat Res 101:406-472
18. Stoica G, Koestner A, Capen C (1984) Neoplasms induced with high single doses of N-ethyl-N-nitrosourea in 30 day-old Sprague Dawley rats, with special emphasis on mammary neoplasia. Anticancer Res 4:5-12 6712176
19. Stoica G, Jacobs R, Koestner A, O'Leary M, Welsch C (1991) ENU-induced in vitro neoplastic transformation of rat mammary epithelial cells. Anticancer Res 11:1783-1792 1837443
20. Haase A (1990) Snapshot FLASH MRI Applications to T1, T2, and chemical shift imaging. Magn Reson Med 13:77-89 2319937
21. Schwickert HC, Roberts TP, Shames DM, van Dijke CF, Disston A, Muhler A, Mann JS, Brasch RC (1995) Quantification of liver blood volume: comparison of ultra short TI inversion recovery echo planar imaging (ULSTIR-EPI), with dynamic 3D-gradient recalled echo imaging. Magn Reson Med 34:845-852 8598811
22. Jain R (1987) Transport of molecules across tumor vasculature. Cancer Metastasis Rev 6:559-593 3327633
23. Jain RK, Baxter LT (1988) Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: Significance of elevated interstitial pressure. Cancer Res 48(24 pt 1):7022-7032 3191477
24. Wedeking P, Sotak CH, Telser J, Kumar K, Chang CA, Tweedle MF (1992) Quantitative dependence of MR signal intensity on tissue concentration of Gd (HP-DO3A) in the nephrectomized rat. Magn Reson Imaging 10:97-108 1545688
25. Shames DM, Kuwatsuru R, Vexler V, Muhler A, Brasch RC (1993) Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: A quantitative non-invasive technique. Magn Reson Med 29:616-622 8505897
26. R Scarff H Torloni 1968 Histological typing of breast tumors World Health Organization Geneva, Switzerland 13-20
27. Bloom H, Richardson W (1957) Histologic grading and prognosis in breast cancer. Br J Cancer 11:359-377 13499785
28. Gossmann A, Helbich TH, Mesiano S, Shames DM, Wendland MF, Roberts TP, Ferrara N, Jaffe RB, Brasch RC (2000) Magnetic resonance imaging in an experimental model of human ovarian cancer demonstrating altered microvascular permeability after inhibition of vascular endothelial growth factor. Am J Obstet Gynecol 183:956-963 11035346
29. van Dijke CF, Brasch RC, Roberts TP, Weidner N, Mathur A, Shames DM, Mann JS, Demsar F, Lang P, Schwickert HC (1996) Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 198:813-818 8628876
30. Tofts PS, Kernmode AG (1991) Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 17:357-367 2062210
31. Larsson HBW, Stubgaard M, Frederiksen JL, Jenssen M, Henriksen O, Paulson OB (1990) Quantitation of blood-brain-barrier defect by magnetic resonance imaging and gadolinium-DTPA in patients with multiple sclerosis and brain tumors. Magn Reson Med 16:117-131 2255233
32. Brix G, Semmler W, Port R, Schad LR, Layer G, Lorenz WJ (1991) Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr 15:621-628 2061479
33. Daldrup-Link HE, Brasch RC (2003) Macromolecular contrast agents for MR mammography: Current status. Eur Radiol 13:354-365 12599002
34. Roberts TP (1997) Physiologic measurements by contrast-enhanced MR imaging: Expectations and limitations. J Magn Reson Imaging 7:82-90 9039597
35. Kroft LJ, Doornbos J, van der Geest RJ, de Roos A (1999) Blood pool contrast agent CMD-A2-Gd-DOTA-enhanced MR imaging of infarcted myocardium in pigs. J Magn Reson Imaging 10:170-177 10441021
36. Kroft LJ, Doornbos J, Benderbous S, de Roos A (1999) Equilibrium phase MR angiography of the aortic arch and abdominal vasculature with the blood pool contrast agent CMD-A2-Gd-DOTA in pigs. J Magn Reson Imaging 9:777-785 10373025
37. Loubeyre P, Canet E, Zhao S, Benderbous S, Amiel M, Revel D (1996) Carboxymethyl-Dextran-Gadolinium-DTPA as a blood pool contrast agent for magnetic resonance angiography. Invest Radiol 31:288-293 8724128
38. Corot C, Violas X, Robert P, Port M (2000) Pharmacokinetics of three gadolinium chelates with different molecular sizes shortly after intravenous injection in rabbits. Relevance to MR angiography. Invest Radiol 4:213-218 10.1097/00004424-200004000-00001
39. Daldrup-Link HE, Link TM, Moller HE, Wiedermann D, Bonnemain B, Corot C, Rummeny EJ (2001) Carboxymethyldextran-A2-Gd-DOTA enhancement patterns in the abdomen and pelvis in an animal model. Eur Radiol 11:1276-1284 11471624
40. Rank F, Dombernowsky P, Bang Jespersen N, Pederson B, Keiding N (1987) Histologic malignancy grading of invasive ductal breast carcinoma; a regression analysis of prognostic factors in low risk carcinomas from a multicentric trial. Cancer 60:1299-1305 3040213